When a person’s airways are not working correctly, the resulting difficulty in breathing can be detrimental to everyday activities and lead to more serious health risks. According to the World Health Organization, asthma – a chronic condition where a person’s airways are narrow and inflamed, making airflow difficult – is... read more →
May
27
Jan
31
Bedfont’s NObreath® monitor for airway inflammation has been cleared for sale in the USA UK, med-tech company, Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation. The NObreath®, which conforms to ATS... read more →
Jan
31
UK, med-tech company, Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation. About the NObreath® FeNO Monitor The NObreath®, which conforms to ATS and ERS guidelines1, is a portable, non-invasive device for... read more →
Mar
25
NHS Organisations can apply for funding from the Pathway Transformation Fund (PTF) to obtain a NObreath® used for asthma diagnosis and management. The NObreath® FeNO monitor from Bedfont® Scientific Ltd. has been included on the Rapid Uptake Products (RUPs) scheme by the NHS Accelerated Access Collaborative (AAC). One of the... read more →
Mar
25
Funding Opportunities for NHS Organisations NHS Organisations can apply for funding from the Pathway Transformation Fund (PTF) to obtain a NObreath® used for asthma diagnosis and management. NObreath® FeNO Monitor: Part of the Rapid Uptake Products (RUPs) Scheme The NObreath® FeNO monitor from Bedfont® Scientific Ltd. has been included in... read more →
May
07
The Trouble with Diagnosing Asthma Approximately 339 million people across the globe suffer from asthma, and asthma-related deaths affect the lives of three families daily. Of these, up to two-thirds of deaths due to attacks are preventable. Inadequate treatment and poor management as well as issues with diagnosis contribute to... read more →
Sep
17
Bedfont announces launch of 2nd generation NObreath at ERS 2018, Paris Bedfont Scientific Ltd. launches their new FeNO monitor exclusively at the world’s largest European Respiratory Society Congress. Medical device manufacturer, Bedfont, specialising in breath analysis for 40+ years, have announced a new and improved 2nd generation NObreath. The monitor... read more →
Sep
09
Bedfont Scientific Ltd. is exhibiting its wide range of medical devices at Arab Health 2019, including its new and improved NObreath® FeNO monitor Breath analysis medical device manufacturer, Bedfont, will return to Arab Health 2019 – the largest healthcare exhibition in the Gulf Cooperation Council. They will be exhibiting their... read more →
Sep
08
Bedfont’s long-standing UK distributor, Intermedical UK, will be exhibiting their breath analysis medical products at the annual ARTP conference. Intermedical UK, a bistributor for nearly 10 years, will be exhibiting the 2nd generation NObreath at the annual Association for Respiratory Technology & Physiology (ARTP) conference and can be found at... read more →